MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Balance Sheets Overview

Current Ratio
1398.93%
Quick Ratio
1398.93%
Cash Ratio
137.71%
Debt to Asset Ratio
7.61%
Unit: Thousand (K) dollars
Assets Breakdown
    • Cash and cash equivalents
    • Prepaid expenses and other curre...
    • Operating lease right-of-use (ro...
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Deferred revenue from a related ...
    • Others
Balance Sheets
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Cash and cash equivalents
32,286
31,120
58,450
22,534
Marketable securities
288,075
195,481
189,656
210,023
Accounts receivable from collaboration with a related party
822
451
974
912
Prepaid expenses and other current assets
6,795
5,561
5,469
3,343
Total current assets
327,978
232,613
254,549
236,812
Property and equipment, net
315
214
221
229
Operating lease right-of-use (rou) assets
2,227
2,369
2,508
2,644
Other assets
312
312
312
312
Total assets
330,832
235,508
257,590
239,997
Accounts payable
1,180
1,129
1,171
1,683
Accrued research and development expenses
2,007
1,538
2,387
3,058
Other accrued expenses
3,342
2,664
7,749
5,728
Deferred revenue from a related party
16,304
29,076
36,904
42,363
Operating lease liabilities - short-term
612
590
569
548
Total current liabilities
23,445
34,997
48,780
53,380
Deferred revenue from a related party - long-term
-
-
0
1,715
Operating lease liabilities - long-term
1,738
1,901
2,059
2,207
Total liabilities
25,183
36,898
50,839
57,302
Common stock, 0.001 par value 150,000,000 shares authorized as of june 30, 2026 and december 31, 2025 19,850,342 and 15,855,329 shares issued and outstanding as of june 30, 2026 and december 31, 2025, respectively
20
16
16
16
Additional paid-in capital
1,151,235
1,040,088
1,038,823
1,036,906
Accumulated other comprehensive loss
-623
-368
-41
-90
Accumulated deficit
-844,983
-841,126
-832,047
-854,137
Total stockholders' equity
305,649
198,610
206,751
182,695
Total liabilities and stockholders' equity
330,832
235,508
257,590
239,997
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Marketable securities$288,075K (465.14%↑ Y/Y)Cash and cashequivalents$32,286K (34.49%↑ Y/Y)Prepaid expenses andother current assets$6,795K (173.22%↑ Y/Y)Accounts receivable fromcollaboration with a related...$822K Total current assets$327,978K (323.38%↑ Y/Y)Operating leaseright-of-use (rou) assets$2,227K (-19.95%↓ Y/Y)Property and equipment,net$315K (43.84%↑ Y/Y)Other assets$312K (0.00%↑ Y/Y)Total assets$330,832K (309.55%↑ Y/Y)Total liabilities andstockholders' equity$330,832K (309.55%↑ Y/Y)Total stockholders'equity$305,649K (1588.67%↑ Y/Y)Total liabilities$25,183K (-59.82%↓ Y/Y)Accumulated deficit-$844,983K (-0.00%↓ Y/Y)Accumulated othercomprehensive loss-$623K (-123.30%↓ Y/Y)Additional paid-in capital$1,151,235K (33.35%↑ Y/Y)Total currentliabilities$23,445K (-50.42%↓ Y/Y)Operating leaseliabilities - long-term$1,738K (-26.07%↓ Y/Y)Common stock, 0.001 parvalue 150,000,000...$20K (150.00%↑ Y/Y)Deferred revenue from arelated party$16,304K (-60.15%↓ Y/Y)Other accruedexpenses$3,342K (-1.91%↓ Y/Y)Accrued research anddevelopment expenses$2,007K (18.69%↑ Y/Y)Accounts payable$1,180K (58.82%↑ Y/Y)Operating leaseliabilities - short-term$612K (14.82%↑ Y/Y)

ASSEMBLY BIOSCIENCES, INC. (ASMB)

ASSEMBLY BIOSCIENCES, INC. (ASMB)